Clinical Trials List
2019-04-01 - 2023-12-07
Phase I/II
Terminated6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- 王馨儀 未分科
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Chien-Chung Lin Division of Thoracic Medicine
- Po-Lan Su Division of Thoracic Medicine
- Yu-Min Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- JENG-SEN TSENG Division of Thoracic Medicine
- Gee-chen Chang Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 王馨儀 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Yen Tu Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- 廖偉志 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- JIN-YUAN SHIH Division of Thoracic Medicine
- 蔡子修 Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 林育麟
- 許嘉林 Division of General Internal Medicine
- Chong-Jen Yu Division of Thoracic Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 廖唯昱
- YEN-TING LIN Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
91 participants
